Suppr超能文献

采用 HPLC-DAD-ESI-IT-TOF-MS 技术研究黄芪总黄酮在体内的存在形式(23 种原型成分和 147 种代谢产物)及其在大鼠体内的分布。

Exploring the In Vivo Existence Forms (23 Original Constituents and 147 Metabolites) of Astragali Radix Total Flavonoids and Their Distributions in Rats Using HPLC-DAD-ESI-IT-TOF-MS.

机构信息

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, No. 38 Xueyuan Road, Beijing 100191, China.

出版信息

Molecules. 2020 Nov 26;25(23):5560. doi: 10.3390/molecules25235560.

Abstract

Astragali Radix total flavonoids (ARTF) is one of the main bioactive components of Astragali Radix (AR), and has many pharmacological effects. However, its metabolism and effective forms remains unclear. The HPLC-DAD-ESI-IT-TOF-MS technique was used to screen and tentatively identify the in vivo original constituents and metabolites of ARTF and to clarify their distribution in rats after oral administration. In addition, modern chromatographic methods were used to isolate the main metabolites from rat urine and NMR spectroscopy was used to elucidate their structures. As a result, 170 compounds (23 original constituents and 147 metabolites) were tentatively identified as forms existing in vivo, 13 of which have the same pharmacological effect with ARTF. Among 170 compounds, three were newly detected original constituents in vivo and 89 were new metabolites of ARTF, from which 12 metabolites were regarded as new compounds. Nineteen original constituents and 65 metabolites were detected in 10 organs. Four metabolites were isolated and identified from rat urine, including a new compound (calycoisn-3'--glucuronide methyl ester), a firstly-isolated metabolite (astraisoflavan-7--glucoside-2'--glucuronide), and two known metabolites (daidzein-7--sulfate and calycosin-3'--glucuronide). The original constituents and metabolites existing in vivo may be material basis for ARTF efficacy, and these findings are helpful for further clarifying the effective forms of ARTF.

摘要

黄芪总黄酮(ARTF)是黄芪(AR)的主要生物活性成分之一,具有多种药理作用。然而,其代谢物和有效形式仍不清楚。本研究采用 HPLC-DAD-ESI-IT-TOF-MS 技术筛选和初步鉴定 ARTF 体内的原始成分和代谢物,并阐明其在大鼠口服给药后的分布。此外,还采用现代色谱方法从大鼠尿液中分离主要代谢物,并通过 NMR 光谱阐明其结构。结果,共初步鉴定出 170 种化合物(23 种原始成分和 147 种代谢物)为体内存在的形式,其中 13 种具有与 ARTF 相同的药理作用。在 170 种化合物中,有 3 种是体内新检测到的原始成分,89 种是 ARTF 的新代谢物,其中 12 种代谢物被认为是新化合物。在 10 个器官中检测到 19 种原始成分和 65 种代谢物。从大鼠尿液中分离并鉴定出 4 种代谢物,包括一种新化合物(calycoisn-3'--glucuronide methyl ester)、一种首次分离得到的代谢物(astraisoflavan-7--glucoside-2'--glucuronide)和两种已知代谢物(daidzein-7--sulfate 和 calycosin-3'--glucuronide)。体内存在的原始成分和代谢物可能是 ARTF 疗效的物质基础,这些发现有助于进一步阐明 ARTF 的有效形式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48a5/7729672/6b456ad6f824/molecules-25-05560-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验